Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/26/21
Lavie Bio Announces the Appointment of Russ Putland as Vice President CommercialPRNewsWire • 05/25/21
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2021PRNewsWire • 05/12/21
Biomica to Present at Jefferies Microbiome-Based Therapeutics Summit, on April 22nd, 2021PRNewsWire • 04/19/21
Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy of BMC128 in MelanomaPRNewsWire • 04/13/21
Canonic of Evogene Group and Tikun Olam (Israel)-Cannbit, sign production and distribution agreements for Canonic products in IsraelPRNewsWire • 03/25/21
Evogene's Subsidiary Biomica: Impressive Pre-Clinical Data For Its Microbiome Therapeutic BMC128Seeking Alpha • 03/17/21
Plastomics and Evogene's Ag-Seed division enter a collaborative agreement targeting novel insect control traits for soybeanPRNewsWire • 03/17/21
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/03/21
Evogene: Ambitious Computational Biology Company Aims To Reward Patient InvestorsSeeking Alpha • 02/25/21
Cannbit, subsidiary of Tikun Olam-Cannbit, and Canonic of Evogene group announce collaboration for the development of novel medical cannabis productsPRNewsWire • 02/24/21
Biomica Announces Participation at the 5th Microbiome Movement Drug Development Europe Conference on January 28-29, 2021 (Virtual Conference)PRNewsWire • 01/20/21
Canonic Announces Signing of First Cultivation Agreement for its Medical Cannabis VarietiesPRNewsWire • 12/23/20
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/18/20